Molecular Cytogenetics Market Professional Survey Report 2019

The high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques are some of the key factors driving the growth of this market.

What the Market Looks Like?

Predicted to grow at a CAGR of 8.4% during the forecast period, the Global Molecular Diagnostics Market is estimated to reach USD 11.54 Billion by the end of 2023. In 2018, North America to dominate the market.

On the basis of technology, the market is broadly segmented into PCR, INAAT, DNA sequencing & NGS, in situ hybridization, DNA microarrays, and other technologies. The PCR segment is expected to account for the largest share of the global molecular diagnostics market in 2019. The large share of this segment is attributed to the growing use of PCR in proteomics and genomics, automation of PCR instruments, and the emergence of advanced technologies like qRT-PCR.

On the basis application, the market is broadly segmented into infectious diseases, oncology, genetic tests, and other applications. The infectious diseases segment is expected to account for the largest share of the global molecular diagnostics market in 2019. The large share of this segment is attributed to the development of advanced assays for different diseases and conditions, significant increase in the prevalence of infectious diseases, and rising awareness about the effective use of molecular diagnostic technologies to control the occurrence and spread of infectious diseases.

On the basis of end user, the Molecular Diagnostics Market is broadly segmented into hospitals and academic laboratories, reference laboratories, and other end users. The hospitals and academic laboratories segment is expected to account for the largest share of the market in 2019. The large share of this segment can primarily be attributed to the large number of diagnostic tests conducted in hospitals.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=833

What Drives the Market?

The growth of the global market for Molecular Diagnostics is primarily influenced by the following factors:

·         High Prevalence of Infectious Diseases and Various Types of Cancers

·         Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics

·         Growth in the Biomarker Identification Market and Advancements in Molecular Techniques

Geographical growth scenario of Molecular Diagnostics Market:

North America is expected to account for the largest share of the global market. The large share of this region is mainly attributed to the high prevalence of infectious diseases and cancers, presence of a highly developed healthcare system and large number of leading national clinical laboratories, easy accessibility to technologically advanced instruments in the region, availability of government funds, and growing applications of molecular diagnostics in genetic disorders and cancer screening.

Leading market players and strategies adopted:

The key players in the Global Molecular Diagnostics Market are Roche (Switzerland), Hologic (US), QIAGEN (Netherlands), Abbott (US), and Danaher (US).

These players focus on inorganic strategies such as acquisitions, partnerships, agreements, and collaborations as well as organic strategies such as expansions and product launches & approvals to sustain their positions in the market.

Read More in Detailed: https://www.marketsandmarkets.com/PressReleases/molecular-diagnostic.asp

Single-cell Analysis Market 2019 Precise Outlook - Merck KGaA (Germany), Becton, Dickinson and Company (U.S.)

The Single-cell Analysis Market, by cell type, is segmented into human, animal, and microbial cells. the human cells segment is expected to account for the largest share of the market. The growing application areas of human stem cells and the rising incidence of diseases such as cancer are the major factors driving the growth of this segment.

Technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and biopharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases are the major factors driving the growth of the market.

The objectives of this study are as follows:

• To define, describe, and forecast the market on the basis of products, cell type, technique, application, end user, and region.
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)

Speak to our analyst and gain crucial industry insights that will help your business grow:

https://www.marketsandmarkets.com/speaktoanalyst.asp?id=171955254

Browse and in-depth TOC on “Single-cell Analysis Market”.

107 — Tables

42 — Figures

175 — Pages

Single-cell Analysis Market, By Technique

• Flow Cytometry
• NGS
• PCR
• Microscopy
• Mass Spectrometry

Request for Free Sample Report @

https://www.marketsandmarkets.com/requestsample.asp?id=171955254

Single-cell Analysis Market, By Region:

• North America
• Europe
• Asia
• Rest of the World (RoW)

The Single-cell Analysis Market is highly fragmented in nature with several big as well as emerging players. Prominent players in this market include Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), General Electric Company (U.K.), Thermo Fisher Scientific Inc. (U.S.), Miltenyi Biotec (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Fluidigm Corporation (U.S.), NanoString Technologies, Inc. (U.S.), and Agilent Technologies (U.S.).

Cold Pain Therapy Market Research, In-Depth Analysis, Key Players, Applications, Forecast 2023

According to the new market research report "Cold Pain Therapy Market by Product (OTC (Gels, Sprays, Patches, Cold Packs, Wraps, Pads, and Roll-Ons), Prescription-Based (Motorized, Non-Motorized Devices), Applications (Musculoskeletal Disorders, Post-Operative Therapy, Sports Medicine, and Post-Trauma Therapy) - Global Forecast to 2023", published by MarketsandMarkets™, the Global Cold Pain Therapy Market is projected to reach USD 2.12 Billion by 2023 from USD 1.69 Billion in 2018, at a CAGR of 4.6% during the forecast period.

Factors such as the increasing incidence of sports injuries and a rising emphasis on exercise, the growing number of hip and knee surgeries across the globe, and a rising need for safer pain management modalities (as compared to oral therapy) are expected to drive the demand for cold pain therapy during the study period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55543905

The OTC products segment is expected to register the highest growth rate during the forecast period

Based on product, the Cold Pain Therapy Market is divided into OTC products and prescription products. OTC products are expected to grow at the highest CAGR during the forecast period. The high patient preference for topical pharmaceuticals as compared to oral medications, owing to their lower side effects, fast pain relief, and convenience, is expected to drive the growth of the OTC products segment in the next five years.

Browse and in-depth TOC on "Cold Pain Therapy Market"

106 - Tables

126 - Figures

273 - Pages

Musculoskeletal disorders are estimated to form the largest segment of the market, by application

The Cold Pain Therapy Market is segmented, by application, into musculoskeletal disorders, post-operative therapy, sports medicine, and post-trauma therapy. The musculoskeletal disorders segment is expected to account for the largest share of the Cold Pain Therapy Market in 2018, owing to the increasing incidence of arthritis, osteoarthritis, back pain, and joint pain; increasing trend of self-care; and the growing preference for topical analgesics to manage musculoskeletal pain.

In 2017, North America accounted for the largest share of the Cold Pain Therapy Market

Geographically, the Cold Pain Therapy Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2017. The growing geriatric population, the high incidence of arthritis and sports injuries, product launches, the large number of surgeries, and stringent regulations on opioid prescription are expected to drive the growth of cold pain therapy products this region.

Read a Press-Release on “Cold Pain Therapy Market”:

https://www.marketsandmarkets.com/PressReleases/cold-pain-therapy.asp

As of 2017, the major players in the Cold Pain Therapy Market are Sanofi (France), DJO Finance (US), and Pfizer (US). Other players in this market include 3M (US), Hisamitsu Pharmaceutical (Japan), Johnson & Johnson (US), Medline Industries (US), Össur (Iceland), Performance Health (US), Beiersdorf (Germany) Rohto Pharmaceutical (US), Breg (US), Romsons Group of Industries (India), Custom Ice (US), and Unexo Life Sciences (India).

Humanized Mouse and Rat Model Market Growth and Analysis, Industry Trends, Size, Shares, Forecast to 2022

According to the new market research report "Humanized Mouse and Rat Model Market by Type (Genetic, Cell-Based (CD34, PBMC, BLT)), Application (Neuroscience, Hematopoesis, Oncology, Immunology & Infectious Diseases) & End User (Pharmaceutical & Biotechnology Companies, CRO)) - Global Forecast", published by MarketsandMarkets™, The humanized rat models market is expected to reach USD 8.9 Million, at a CAGR of 8.4% during the forecast period. The humanized mouse models market is projected to reach USD 128.9 Million, at a CAGR of 9.9% during the forecast period.

Growth in this market can primarily be attributed to factors such as the growing demand of personalized medicine, continuous support in the form of investments and grants from the government and private sectors, increasing number of R&D activities in pharmaceutical and biotechnology companies, and the increasing number of research activities involving humanized models. Increasing production of monoclonal antibodies and rising demand for humanized rat models are expected to provide a wide range of growth opportunities for players in the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131763955

The oncology segment commanded the largest share of the humanized mouse models market.

By application, the humanized mouse models market is categorized into oncology, immunology and infectious diseases, neuroscience, hematopoiesis, toxicology, and other applications. Of all these application segments, oncology accounted for the largest share of the humanized mouse models market in 2017. The increasing research activities and growing funding from various governments to carry out research studies on cancer are the major factors driving the growth of this segment.

Browse and in-depth TOC on "Humanized Mouse and Rat Model Market"

94 - Tables

42 - Figures

189 - Pages

Cell-based humanized mouse models to grow at the highest CAGR during the forecast period

By type, the humanized mouse models market is categorized into genetic and cell-based humanized mouse models. The cell-based humanized mouse models segment is expected to grow at the highest CAGR during the study period (2017–2022). The high growth of this segment can be attributed to the growing applications of cell-based humanized mouse models.

The cell-based humanized mouse models segment is further categorized into CD34, PBMC, and BLT humanized mouse models. In 2017, the CD34 models segment commanded the largest share of the cell-based humanized mouse models market and is expected to grow at the highest CAGR during the forecast period.

Contract Research Organizations (CROs) to dominate the humanized mouse models market during the forecast period

By end user, the humanized mouse models market is categorized into pharmaceutical & biotechnology companies, contract research organizations (CRO), and academic & research institutions. The contract research organizations (CROs) segment is projected to grow at the highest CAGR during the forecast period. Growth in this segment is largely due to the increasing number of pharmaceutical companies outsourcing their preclinical studies to contract research organizations (CROs).

North America dominated the market in 2017

North America dominated the global humanized mouse models market in 2017. Growth in this regional segment can be attributed to the increasing monoclonal antibody production, preclinical activities by CROs and pharmaceutical R&D, continued and responsible use of animals ensured by animal care organizations, growing biomedical research in the US along with government support for the development of protein drugs, and growing stem cell research in Canada.

Read More About Humanized Mouse and Rat Model Market: https://www.marketsandmarkets.com/PressReleases/humanized-mouse-model.asp

The major market players in the humanized mouse models market include The Jackson Laboratory (US), Taconic Biosciences, Inc. (US), Horizon Discovery Group plc (UK), genOway, S.A. (France), Charles River Laboratories (US), Harbour Antibodies BV (China), Hera BioLabs (US), Vitalstar Biotechnology Co., Ltd. (China), inGenious Targeting Laboratory (US), AXENIS S.A.S (France), Crown Bioscience, Inc. (US), Transgenic, Inc. (Japan), and Champions Oncology, Inc. (US). The major players in the humanized rat models market include Horizon Discovery Group plc (UK), Hera BioLabs (US), and Yecuris Corporation (US).

Global Rehabilitation Equipment Market 2019 Industry Trends, Growth Forecast

According to the new market research report “Rehabilitation Equipment Market by Type (Mobility (Wheelchair, Assist Device), Body Support (Lift, Sling), Exercise (Upper, Lower Body), Living Aids (Reading, Writing)), Application (Physiotherapy, OT), End User (Hospital, Clinic, Home Care) — Forecast”, published by MarketsandMarkets™, the global Rehabilitation Equipment Market is expected to reach 14.91 Billion, at a CAGR of 8.6% during the forecast period.

The Research Report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

The growth of this market is mainly driven by factors such as growing incidence of disabilities resulting from non-communicable diseases, favorable healthcare reforms, and rapid growth in the geriatric population coupled with the rising prevalence of chronic diseases. However, a high cost & maintenance expense of rehabilitation equipment is the key factor that is expected to restrain the growth of this market to a certain extent.

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194775519

In this report, the Rehabilitation Equipment Market has been segmented on the basis of type, application, end user, and region. Based on type, the Rehabilitation Equipment Market is segmented into mobility equipment, body support devices, exercise equipment, and daily living aids. In 2016, the daily living aids segment accounted for the largest share of the market.

Browse and in-depth TOC on “Rehabilitation Equipment Market”

154 — Tables

31 — Figures

162 — Pages

On the basis of the end user, the Rehabilitation Equipment Market is segmented into hospitals & clinics, rehabilitation centers, physiotherapy centers, and home care settings. In 2016, the hospitals & clinics segment accounted for the largest share of the Rehabilitation Equipment Market. This can be attributed to factors such as higher quality of treatment provided in hospitals and clinics, as opposed to other end-user segments, increasing sports injuries, the growth of the disabled and aged populations, and supportive reimbursement policies for hospital treatment.

Based on the region, the Rehabilitation Equipment Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, Europe dominated the market, followed by North America. Factors such as supportive government initiatives for safe patient handling, growth in the geriatric population, and the presence of a large number of players in Europe are driving the growth of the European Rehabilitation Equipment Market.

Read a Press-Release on “Rehab Equipment Market”

https://www.marketsandmarkets.com/PressReleases/rehabilitation-equipment.asp

The Rehabilitation Equipment Market is fragmented in nature with several big and emerging players. This market is dominated by key players such as Invacare Corporation (U.S.), Medline Industries, Inc. (U.S.), Dynatronics Corporation (U.S.), Drive DeVilbiss Healthcare (U.S.), Changzhou Qian Jing Rehabilitation Co., Ltd. (China), Carex Health Brands (U.S.), Roma Medical (U.K.), Caremax Rehabilitation Equipment Co. Ltd. (China), GF Health Products, Inc. (U.S.), and HEMC (Hospital Equipment Manufacturing Company) (India).

Veterinary Chemistry Analyzer Market Revenue, Demand, Opportunity, Segment and Key Trends 2019

According to the new market research report “Veterinary Chemistry Analyzer Market by Product (Chemistry Analyzer, Glucometer, Consumables (Panel, Test Strip, Reagent)) Application (Blood Chemistry Analysis, Urinalysis, Glucose Monitoring) & Animal (Companion & Livestock) — Global Forecast”,published by MarketsandMarkets™, the Global Veterinary Chemistry Analyzer Market is estimated to grow at a CAGR of 8.7%, to reach USD 1,205.2 Million.

The growth in this market is majorly attributed to factors such as growing livestock and companion animal population, rising animal healthcare expenditure, rising pet adoption, growing demand for animal-derived food products, raising awareness about zoonotic diseases, and an increasing number of veterinary practitioners across the globe.

Read a Press Release on “Veterinary Chemistry Analyzer Market”:

https://www.marketsandmarkets.com/PressReleases/veterinary-chemistry-analyzer.asp

The Global Veterinary Chemistry Analyzer Market is segmented on the basis of product, application, animal type, and region. On the basis of product, this market is segmented into instruments and consumables (panels, kits, test strips, and reagents). In 2016, the consumables segment accounted for the largest share of the global Veterinary Chemistry Analyzer Market. It is expected to register the highest growth during the forecast period. The high growth of this segment is mainly attributed to the increased adoption of the pre-loaded multiple reagent panels and pre-loaded single slide reagent panels by the end users.

Browse and in-depth TOC on “Veterinary Chemistry Analyzer Market”

206 — Tables

24 — Figures

250 — Pages

On the basis of application, the market is categorized into blood chemistry analysis, urinalysis, glucose monitoring, and blood gas-electrolyte analysis. The blood chemistry analysis segment accounted for the largest share, while the glucose-monitoring segment is expected to witness the highest growth during the forecast period. The Veterinary Chemistry Analyzer Market is further segmented, on the basis of animal type, into companion animals and livestock. The companion animal segment accounted for the largest share of the market. This segment is also expected to register the highest growth during the forecast period.

The report also provides a detailed geographic analysis of the Veterinary Chemistry Analyzer Market covering developed and emerging economies. The developed market includes the U.S., Canada, Germany, the U.K., France, Italy, Spain, and Japan while the emerging market includes China, India, and Latin America. The U.S. attributed the largest share of the developed market owing to its well-established animal healthcare systems. The large share of this regional market segment is driven by increasing demand for animal-derived food products, rising animal healthcare expenditure, growing animal population, and raising awareness about zoonotic diseases.

Some of the prominent players in this market are IDEXX Laboratories, Inc. (U.S.), Abaxis, Inc. (U.S.), Heska Corporation (U.S.), Randox Laboratories Ltd. (U.K.), ARKRAY, Inc. (Japan), Eurolyser Diagnostica GmbH (Austria), Alfa Wassermann Inc. (U.S.), DiaSys Diagnostic Systems, USA, LLC (U.S.), Diconex SA (Argentina), Chengdu Seamaty Technology Co., Ltd.(China), Biochemical Systems International Srl (Italy), ELITechGroup (France), and URIT Medical Electronic Group Co. Ltd (China).

Know more about key industry players:

https://www.marketsandmarkets.com/ResearchInsight/veterinary-chemistry-analyzer-market.asp

Global Antinuclear Antibody Test Market 2019: Opportunities, Challenges, and Forecast

The research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the ANA testing market, along with revenue estimates & forecasts and market share analysis.

Don’t miss out on business opportunities in Antinuclear Antibody Test Market

The Global Antinuclear Antibody Test Market is expected to reach USD 1,476.1 Million, at a CAGR of 12.4%

The increasing prevalence of autoimmune diseases and increasing healthcare expenditure worldwide are the major factors driving the growth of this market.

This report segments this ANA testing market based on products, diseases, techniques, end users, and regions. In the product's market, the assay kits & reagents segment is expected to account for the largest share. This segment is also expected to grow at the highest CAGR during the forecast period due to the growth in the number of reagent rental agreements and the increasing prevalence of autoimmune diseases worldwide.

Browse and in-depth TOC on “Antinuclear Antibody Test Market”

73 — Tables

102 — Figures

166 — Pages

Based on techniques, the Antinuclear Antibody Test Market is segmented into three broad segment, namely, enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), and multiplex assay. The ELISA segment is expected to account for the largest share of this market owing to expanding applications of ANA in autoimmune disease testing and therapeutic drug level monitoring.

The Antinuclear Antibody Test Market’s end-user segments in this market include clinical laboratories, hospitals, POLs, and other end users. The hospitals segment is expected to account for the largest share in 2016, primarily due to the rising healthcare spending which has resulted in a growth in use of ANA testing products in hospitals. Based on region, the global Antinuclear Antibody Test Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as rising geriatric population and increasing prevalence of autoimmune diseases.

Request for Free Sample Report @

https://www.marketsandmarkets.com/requestsampleNew.asp?id=218189007

Key players in the Antinuclear Antibody Test Market include Alere Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), ERBA Diagnostics, Inc. (U.S.), Trinity Biotech plc (Ireland), Thermo Fisher Scientific, Inc. (U.S.), Antibodies, Inc. (U.S.), EUROIMMUN AG (Germany), Immuno Concepts (U.S.), Inova Diagnostics (U.S.), and Zeus Scientific, Inc. (U.S.).

Needle-Free Injection System Market Professional Survey Report 2019

According to Latest Market research report Published by MarketsandMarkets the “Needle-Free Injection System Market Size, Share, Demand and Growth Analysis, forecast” the Global Market is expected to reach $ 20.17 billion, at a CAGR of 15.5%

Growth in this market is mainly driven by the growing prevalence of the chronic disease, increasing the incidence of communicable disease due to needlestick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861

key players operating in the Global Needle-Free Injection System Market;

Companies are focusing on adopting organic as well as inorganic growth strategies such as acquisition, agreements, collaboration, expansion, product upgrades, partnerships, and others (approvals and certifications) to synergistically offer advanced needle-free injection solutions in the market

Key market players include Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).

Major Drivers Impacting the Needle-Free Injection System Market;

· Growing Prevalence of Chronic Diseases

· Increasing Incidence of Communicable Diseases Due to Needlestick Injuries

· Rise in Demand for Self-Injection Devices

· Rising Demand for Biosimilars and Vaccination

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861

Global Needle-Free Injection System Market Segmentation:

Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors, and vibration-based needle-free injectors. The jet-based needle-free injectors are expected to witness the highest growth during the forecast period, due to their advantages over the other injector systems.

Global Needle-Free Injection System Market, by type of Medication

• Liquid-based needle-free injectors
• Powder-based needle-free injectors
• Projectile/depot-based needle-free injectors

Global Needle-Free Injection System Market, by Application

• Vaccine Needle-free delivery
• Insulin Needle-free delivery
• Pain Management Needle-free delivery
• Oncology Needle-free delivery